Drawing from implementation lessons and successes in other industries, possible strategy shifts to pharma’s pricing playbook are explored.
Caitlyn Macdonald
Advertisement
Articles by Caitlyn Macdonald
Advertisement
Latest Updated Articles
Pricing Turning Point: The Case for Innovating Pharma’s ModelPublished: March 6th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Submits NDA to FDA for CagriSema
2
Senate Passes Biosecure Act
3
The End of the Rebate Era? What HR Leaders and Pharmacy Consultants Need to Know About Biosimilars
4
Eli Lilly Announces Topline Results From Phase III Trial Studying Oral GLP-1 Therapy Orforglipron
5